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Résumé
La survie des patients après transplantation cardiaque est limitée par
l’apparition d’une forme d’athérosclérose accélérée au niveau des artères
coronaires menant à des infarctus silencieux et une perte progressive de la
fonction du greffon. L’apparition précoce d’une dysfonction endothéliale au
niveau des artères coronaires prédit le développement de la maladie du
greffon 1 an après la transplantation. Les facteurs impliqués dans
l’apparition de cette dysfonction endothéliale incluent le rejet cellulaire et
humoral, la dyslipidérnie, l’infection au cytomégalovirus, l’exposition des
artères coronaires aux solutions cardioplégiques, l’ischémie froide, et le type
de solution de préservation utilisé lors du prélèvement cardiaque.
Le premier article rapporte l’effet de l’utilisation du Celsior, une
nouvelle solution de préservation spécifiquement conçue pour la greffe
cardiaque, sur la fonction endothéliale d’artères coronaires porcines dans un
modèle de préservation cardiaque comparé à deux stratégies courantes de
cardioplégie et de préservation utilisées en greffe cardiaque. Les résultats
obtenus démontrent que l’utilisation du Celsior pour l’induction de la
cardioplégie et la préservation myocardique a un effet protecteur à court
terme sur les relaxations endothélium-dépendantes médiées par les protéines
G comparé aux autres stratégies. Ces résultats pourraient être associés avec
des meilleurs résultats à court et moyen terme en greffe cardiaque avec
l’utilisation du Celsior lors du prélèvement.
Le deuxième article rapporte les effets protecteurs du Celsior sur la
fonction endothéliale des artères coronariennes épicardiques porcine à 30
jours post-transplantation cardiaque hétérotopique chez le porc. L’utilisation
du Celsior pour l’induction de la cardioplégie et la préservation est comparé
avec deux stratégies de cardioplégie et préservation utilisées en greffe
cardiaque. Les résultats obtenus démontrent une meilleure réactivité
endothéliale des artères coronaires épicardiques préservées au Celsior 1
mois après la transplantation. L’utilisation du Celsior pour l’induction de la
cardioplégie et la préservation pourrait potentiellement réduire l’incidence
d’athérosclérose accélérée du greffon comparé aux autres solutions en
préservant les effets protecteurs de l’endothélium sur la paroi vasculaire.
Mots clés : endothélium, athérosclérose précoce, cardioplégie, préservation,
greffe cardiaque.
Summary
Suiwival afier heart transplantation is lirnited by the appearance of an
accelerated form of atherosclerosis in the coronary arteries that leads to
suent infarcts and progressive lost of grafi function. Early appearance of
coronary artery endothelial dysfunction is predictive of deveÏopment of
coronary allografi vasculopathy one year afier transplantation. Factors which
have been incriminated as the cause of this dysfunction include cellular and
humoral rejection, hypercholesterolemia, CMV infection, exposure of
coronal-y arteries to cardioplegic solutions, cold ischemia, preservation
solutions, and reperfusion afier implantation.
The first article evaluates the effects of Celsior (an antioxidant
solution specifically designed for cardiac preservation) in a model of heart
preservation (4 hours to mimic clinical conditions) cornpared to two
commonly used cardioplegic and preservation strategies on coronary artery
endothelial function in a porcine model. The resuits demonstrate that Celsior
cardiopÏegia and storage allowed for functional recovery of endothelium
dependent relaxations to serotonin cornpared to saline preservation. The
observed effect may be associated with an improvement in both short- ad
long-term outcome in heart transplantation.
The second article examined the potential protective effects of
Celsior, a new preservation solution specifically designed for heart
transplantation, on coronary endothelial reactivity at 1 month post
transplantation cornpared with crystalloid and blood based cardioplegic
solutions. The results dernonstrated that the use ofcrystalloid solution causes
a decrease in endothelium-dependent relaxations to agonists as compared to
blood and Celsior solutions. The use of Celsior has a protective effect on
endothelial function at 1 rnonth and potentially reduces the incidence of
coronary allografi vasculopathy cornpared to other solutions by preserving
the protective effects ofthe endothelium on the vascular wall.
Key words: Endothelium, accelerated atherosclerosis, cardioplegia,
preservation, heart transplantation.
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Introduction
The Normal Endothehum
The normal endothelium contributes to vasomotor tone and to the
maintenance of a non-thrornbogenic vascular surface, acts as a selective
barrier for the transport of macrornolecules and solutes needed for cellular
metabolisrn, contributes to the proliferation of the underlying smooth
muscle, and regulates the adhesion and transmigration of neutrophils,
monocytes and lymphocytes. These endothelial properties are due to its
capacity to sense hormonal and hemodynamic stimuli by three basic
rnechanisms: the secretion of endothelium-dependent factors, the expression
on its surface of celi adhesion molecules and signal transduction coupling
molecules, and morphological changes.
11e role of the vascular endothelium was first recognized by
Furchgott and Zawadski in 1980 (1) following the discovery of the
endothelium-dependency ofthe dilator response to acetylcholine. Since then,
three pathways have been described that mediate endothelium-dependent
relaxations. Endothelium-dependent vasodilatation can be mediated by the
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release of nitric oxide (NO), prostacyclin, or endothelium-dependent
hyperpolarizing factor (EDHF) (Figure 1) (1-6).
1) Nitric Oxide
Nitric oxide is a labile molecule and diffuses readily through plasma
membranes. It is formed from L-arginine via the constitutive form of nitric
oxide synthase (7,8) (NO synthase III). The activation of this enzyme
depends on the intracellular concentration of calcium ion in the endothelial
ceil, on calmodulin, and requires nicotinamide adenine dinucleotide
phosphate (NADPH) for optimal activity (9). NO synthase can be
competitively inhibited by analogs of L-arginine N-monomethyl-L-arginine
(L-NMIvIA) and N-nitro-L-arginine (Figure 1) (9). There are three types of
nitric oxide synthase enzymes responsible for the production of NO. Nitric
oxide synthase type I (nNOS) exists in the neuronal cells of the brain in
peripheral nonadrenergic noncholinergic neurons (10). It produces NO for
the activation of the signal transduction pathways in neurotransmission.
Inducible NOS II (iNOS) is produced by macrophages in response to
endotoxins, rnicro-organisms, or cytokine secretion. INOS has shown
cytotoxic effects on invading bacteria and tumor celis, is capable of
producing much greater quantities of NO than the other isoforms (11), and is
responsible for the vasodilatatory effect seen in sepsis and septic shock.
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Endotheliai ceils generate NOS III (eNOS) which produces NO one of
several endothelium-derived relaxing factor (EDRF). Most vasoactive
stimuli such as bradykinin and shear stress mediate their activities through
the production of NO derived from the endothelium. Ccli membrane-bound
G-proteins transduce signais intracellularly and play a pivotai role in celi
bioiogy (12-14). These intraceilular signais cause an increase in inositol
triphosphate and diacylglycerol which in tum alter calcium leveis within the
ceil and activate Ca++ dependent proteins such as eNOS. NO diffuses into
smooth muscle ceils within 200 jim and causes relaxation via activation of
guanylate cyclase in vascular srnooth muscle (15) (Figure 2). Since NO has a
short half-life of 6 seconds, its effects are stimulus and dose-dependent.
Once entered into the smooth muscle cdl (SMC), NO binds to soluble
guanylate cyclase which stimulates the conversion of GTP to guanosine
3’,5’-monophosphate (cGMP). cGMP is associated with inhibition of $MC
contractility by shifling the intracellular calcium (Ca++) to a lower
concentration. Since an increased concentration of Ca++ is required for the
dephosphorylation of the rnyosin light chain kinase and thus smooth muscle
contraction, rises in the cGIVW concentration induce vasorelaxation (16-1 8).
The production of NO significantly contributes to endothelium-dependent
relaxations in coronary, systemic, mesenteric, and pulmonary beds. Tts
14
contribution to vasomotor tone is suggested by the fact that inhibitors of NO
cause a generaiized vasoconstriction and a rise in arterial bÏood pressure in
animais and humans (19,20). Endothelial ceils also secrete NO in the lumen
of biood vesseis which is imrnediately neutralized in normai situations by
the presence of oxyhemoglobin. Thus NO acts as an interface between the
blood stream and the endothelium and in this way inhibits platelet and
leukocyte adhesion. Physiologically, platelets norrnally circulate in the
peripheral bloodstream in an inactivated state due to the liberation of NO
and prostacyclin by the endothelium. Both mediators increase cGMP or
cAIVW in piatelets and thereby prevent platelet adhesion and aggregation
(21-24). At sites where plateiets are activated, they release active mediators
which interact with endothelial receptors (Figure 5) and cause endothelium
dependent relaxations mediated by NO. The presence of endotheiium
inhibits to a large degree the vasoconstriction induced by thrornboxane A2
and serotonin derived from platelets during aggregation. The piateiet-derived
mediator primarily responsible for the stimulation of NO formation is ADP
and to a lesser extent serotonin, which act respectively on Py-purinergic and
5-HT1d receptors (25,26). Serotonin aiso binds to 5HT2 receptors on smooth
muscle ceils which cause vasoconstriction when stimuiated. The action of
platelet products and thrombin is crucial for the protective role of the
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endothelium against inappropriate coagulation. Not onÏy does the release of
NO induce a direct relaxation of srnooth muscle thereby inducing
vasodilatation and preventing platelet microaggregation, but the endothelial
barrier prevents the vasoconstricting substances (thrornboxane A2 and
serotonin) from acting on the vascular srnooth muscle. When the endothelial
barrier is darnaged, platelet aggregation goes unopposed with the liberation
of thromboxane A2 and serotonin and the platelet activator effect of
thrombin (25).
Numerous neurohormonal stimuli can cause the release of nitric oxide
from endothelial ceils (Figure 3). Circulating hormones such as
catecholarnines or vasopressin, prostanoids such as histamine or bradykinin,
mediators derived from pÏatelets (serotonin, ADP) or forrned during
coagulation (thrornbin) can ah bind to specific receptors on the surface of
endothelial cells and cause the activation of eNO$ via distinct signal
transduction pathways (Figure 4). For example, Œ-adrenergic, serotonin, and
thrornbin receptors are coupled to a Gi-protein pathway which is sensitive to
pertussis toxin whereas ADP and bradykinin (which also mediates release
EDHF) mediate production of NO via activation of Gq-proteins (27,2$).
Activation of both these protein pathways by the binding of agonists to their
cell surface receptors leads to an intracellular increase in inositol
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triphosphate and diacylglycerol, an increase in intracellular calcium and
activation of eNOS. The Gi-protein mediated pathway is one of the first
pathways affected in many cardiovascular diseases such as acute and chronic
cardiac rejection (29,30) and atherosclerosis (31,32), hypercholesteroïemia,
and ischernia-reperfusion injury and may be an early marker ofpathological
activation ofthe endothelium in vascular diseases. The Gq-protein rnediated
pathway is more robust and is usually affected later in the disease process.
2) Prostacyclin (PGI2)
Prostacyclin is predominantly forrned by the endothelium, although
vascular smooth muscle ceils have a lesser capacity to produce prostanoids.
It is a major byproduct of cyclooxygenase and induces SMC relaxation in
response to hypoxia and shear forces. Prostacyclin causes vasodilatation by
increasing cyclic AMP in vascular smooth muscle cells. In rnost vessels, the
contribution ofprostacyclin to endothelium-dependent relaxation is minimal
but it acts synergistically with NO to prevent platelet aggregation (33,34).
3) Endothelium-derived Hyperpolarizing Factor
Recent studies have demonstrated that acetylcholine and other
endothelium-dependent vasorelaxants cause an endothelium-dependent
hyperpolarization from a diffusible factor derived from the endothelium
(endothelium derived hyperpolarizing factor) distinct from NO and
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prostacyclin (35-39). Indeed, inhibitors of nitric oxide formation or
cyclooxygenase such as L-NMMA or indornethacin only partially inhibit
endothelium-dependent relaxations to bradykinin. The chemical nature of
EDHF remains to be determined but it causes hyperpolarization of vascular
smooth muscle ceils via ATP-dependent potassium channels (40-42). The
exact type of potassium channel is unknown but is probably calcium
dependent. The contribution of EDHF to endothelium-dependent relaxation
varies according to the size of the vesse! but is greatest in resistance arteries
(38,43).
4) Endothe]ium-derived Contracting Factors
The endothelium can a!so produce contracting factors derived from
the cyclooxygenase pathway, narnely prostaglandin H2, arachidonic acid,
and thromboxane A2 (44), as wel! as endothelin-1(44-49). Endothelin-1 is
more likely to play a role in the long term regulation of vasomotor tone
rather than the spontaneous vasoconstriction of the vascular smooth muscle.
Endothe!in production is stimulated by chemical stimuli such as hypoxia,
and mechanica! forces, as well as agonists such as thrombin, vasopressin,
and angiotensin II.
1$
Coronary Allograft Vasculopatliy and Endothelial Dysfunction
Heart transplantation remains the only efficacious treatment for
terminal heart failure but has an associated 5-year survival of 75% owing to
the developrnent of graft coronary vasculopathy, which leads to suent
infarcts, grafi failure, and sudden death (50-52). It is estirnated that over
50% of patients have significant stenotic disease at 3 years afier
transplantation using intravascular ultrasound for evaluation and 50% of
these will develop graft failure (53). Most ofthese individuals do not present
symptoms of the disease because of cardiac denervation occurring during
harvesting. The first clinical manifestations are often arrythmias, heart
failure, or sudden death. Grafi coronary vasculopathy is manifested by a
unique and unusually accelerated form of coronary disease affecting both the
smaller intramyocardial vessels and the larger epicardial arteries (54).
Cardiac allografi vasculopathy affects only allograft vessels, sparing ail
native vesseis. Intimai hyperplasia is visible in up to 75% of patients at 1
year using IVUS (55).
The pathogenesis and morphological pattems of coronary allograft
vasculopathy are yet to be fully elucidated but the histological changes have
been described. Pathological examination of coronary arteries from human
cardiac allografts have shown that compared with conventional
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atherosclerotic plaques, the disease is diffuse rather than segmental,
concentric in nature rather than eccentric, deveÏops within months to years,
and also occurs in the pediatric population afier transplantation (56,57-61).
The initial lesion is characterized by an early intimai proliferation which
progresses with time to plaques incorporating lipid deposits and late
calcification of coronary vessels (54). These histopathological changes are a
function of tirne; earÏy afier transplantation a vasculitis predominates
characterized by cellular infiltrates consisting of rnodified smooth muscle
ceils, T lymphocytes, and rnonocytes/macrophages which progress to focal
atherosclerotic plaques (59,62). The intimai hyperplasia is diffuse which
explains the obliteration of the small distal resistance vessels before the
larger epicardial coronary arteries (63).
Coronary endothelial dysfunction has been shown to be a precursor to
the developrnent of intimai hyperpiasia and atherosclerosis in many vascular
diseases such as hypercholesterolemia and diabetes. It also precedes the
development of coronary allograft vasculopathy as is shown by an impaired
endothelium-dependent relaxation to different stimuli at different time points
afier transplantation: the vasomotor response to acetylcholine (64,65) and
the cold pressor test (66) may be abnormal a few weeks to rnonths afier
transplantation while exercise-induced vasodilatation is typically maintained
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for several months to years (67). These abnormalities are predictive of the
developrnent of graft vasculopathy and may predict an adverse clinical
outcome (50,68-69). Endothelial ceil damage also leads to enhanced release
of endotheÏin, a potent vasoconstrictor peptide, with subsequent increase in
coronary vascular resistance and diminished myocardial blood flow (70).
The tirne course of coronary endothelial dysfunction in acute untreated
rejection has been characterized (30) and begins with an endothelial
dysfunction due to a progressive destruction of the endothelial lining 5 days
after heart transplantation which initially involves Gi-protein mediated
relaxations. The dysfunction worsens over time and cornes to affect ail
endothelial mechanisrns and vascular srnooth muscle. Contradictory resuits
have been reported in the relationship between endothelial dysfunction and
vessel morphology. Thus, an irnpaired vasomotor response to papaverine
induced increased coronary blood ftow has been described in transplant
patients with significant abnormalities of the vessel wall (71) while other
studies have flot confirrned the relationship between the impairment of
endotheliurn-dependent and independent vasodilatation and degree of
intimai hyperpiasia (71-73). Therefore, it appears there is no simple
reiationship between coronary artery structure and function in transplanted
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patients; some normal appearing vessels do flot dilate whule others with
intimai hyperpiasia show good vasodilatation (74).
The endothelium lies in a strategic anatomical position between the
circulating blood and the vascular srnooth muscle ceil. for this reason, the
graft’s endothelium is the prirnary target of the immunological response to
the aliografi due to the expression of alloantigens on its surface in
conjunction with MHC molecules (direct response), thereby activating host
helper T celis (72). Activated host helper T ceils release interleukin-2 that
leads to the proliferation of other alloreactive celis with the secretion of
cytokines (73). In response, the endotheiiurn expresses celi surface antigens
and adhesion molecules (ICAM,VCAM) and secretes chemoattractant
factors to macrophages which then enter the vessel wall along with
lymphocytes which enhance the migration and proiiferation of vascular
smooth muscle ceils. This leads to an endotheiiaÏ dysfunction which
significantly contributes to the increase of platelet-vessel wall interaction,
vasoconstriction, and proliferation of vascular smooth muscle ceils. Under
these conditions, endothelium-dependent vasodilatation i s reduced and
endothelium-dependent constrictor responses are augmented.
Although the immunoiogical hypothesis for endothelial dysfunction
as a precursor to coronary allograft vasculopathy is a valid one, numerous
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factors may trigger endothelial dysftinction (74,75) after transplantation,
including cellular and humoral rejection as described above,
hyperlipidemia, cytomegalovirus reactivation, and the toxic effects of
immunosuppressants such as cyciosporin A. The process of transplantation
itself exposes coronary arteries to cardioplegic solutions (76), cold ischernia
(77), preservation solutions (78), and reperfusion after implantation (79-$1)
which may cause pathologie activation of the endothelium rendering it
dysfunctional. Cold ischernic storage can be deleterious to the preserved
organ by causing celiular swelling, extracellular edema, cellular acidosis,
depletion ofmetabolic substances, reperfusion injury, calcium overload, and
endothelial injury. Injury caused by reperfusion is attributed to ischemic ccli
sweiling, the no-reflow phenomenon which is the failure of unifonri blood
flow to retum to ail ischemic tissue, reperfusion-induced hemorrhage, and
oxygen-derived free radicals (82). The role ofischemia and reperfusion is an
early, transient cofactor of endothelial injury after transplantation ($3,84).
The activation of the microvascular endothelium leads to the production of
oxygen free radicals with subsequent activation of leukocytes and
macrophages. Activated celis release oxygen radicals and other mediators
such as cytokines, proteases, and eicosanoids. These free radicals can
scavenge endothelium-derived nitric oxide (NO) or have direct cytotoxic
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effects on the endothelium to induce a coronary endothelial dysfunction. The
chief reactive oxygen species is the superoxide anion. Ail celis generate a
basic level of superoxide anion, but the main producers are the mitochondria
(85). In the setting of acute injury, superoxide anion production is rnediated
chiefly by the enzymes xanthine oxidase, nitric oxide synthase, and by
neutrophiis ($6). In ischemia-reperfusion, the effects of NO can be both
beneficial and detrimental. The vasodilatation induced by NO may be
essential for the perftision of organs during shock (87). The main harmful
effects of NO is the production of peroxynitrite. When NO combines with
the superoxide anion, the resultant peroxynitrite is a much stronger oxidant
than either of its constituents resulting in apoptosis or cytotoxicity. Thus,
postischernic reperfusion injury is a network of interactions mediated by a
large variety of oxidative molecules and aggressive mediators Jeading to an
early endothelial dysfunction.
Endothelial dysfunction afier transplantation is a consequence of
initial injury to the endothelium by mechanisms described above. When the
endothelial ceil is injured, it becornes activated and plays a pivotai role in
the development of atherosclerosis and allograft vascular disease.
Endotheiial activation may lead to the induction ofgenes which are normaliy
suppressed and inhibition ofbeneficiai genes (8$). The activated endothelial
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celi can have critical interactions with smooth muscle celis, macrophages,
and platelets, ail of which play a criticai role in the atherosclerotic and
coronary artery vascuiopathy process (8$). It has been hypothesized that a
transcription factor, nuclear factor-kappa B (89), and other signaling
pathways induce the inappropriate and darnaging gene expression by
activated endothelial celis. The damaged endothelium results in
dysfunctional cellular activities manifested as alterations in endothelial
permeability, ioss of antithrombogenic characteristics with microthrombi
formation, increased adhesion of leucocytes, and release of vasoactive
substances and growth factors ($8). The endothelium norrnally provides a
barrier to the passage of plasma proteins and growth factors into the media,
but in the presence of endotheliai injury, proteins pass through the
endotheliai layer and accumulate in the media (90). Growth factors then
stimulate smooth muscle cells to migrate into the intima and proliferate,
leading to progressive intimal hyperpiasia (91). Ail of these consequences
further promote the developrnent of atheroscierosis and ailografi
vascuiopathy.
Preservation Solutions and the Endothelium
Despite the ongoing research in order to extend the length of
preservation of organs for transplantation, the ciinicaliy acceptable ischemic
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time for heart transplantation remains 4-8 hours (92,93), an amount of time
significantly less than for liver (94) and kidney (95) transplantation which
are 24 and 48 hours respectively. A retrospective analysis ofheart transplant
centers in the United Network of Organ Sharing (96) showed that 167
different preservation solutions are used in heart transplantation today and
only 11% of centers use University of Wisconsin solution (UW). Less than
optimal solutions may be sufficient if the cold ischernic period is kept < 4
hours but this is rarely the case in a clinical setting. A multivariate analysis
of data from the International Heart Transplant Registry (97) showed that
ischemic time has a significant (P<O.001) effect on 1 and 5 year mortality.
Trnprovements in myocardial preservation solutions can increase the safety
period of cold ischemic time without increasing the risk of mortality, and
may improve short and long-tenri cardiac function after transplantation.
Superior myocardial preservation may also increase the donor pool by
allowing the use of suboptimal donors.
Preservation solutions can prevent endothelial ceils from injury from
oxygen-derived free radicals during the ischemic period. Niisson et al
showed that there was a nonselective decrease in endothelium-dependent
relaxations imrnediately afier perfusion with crystalloid cardioplegia with
functional recovery after 5 hours of cold storage whereas comparable
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changes in function of the endothelium were flot observed afier perfusion
with a blood cardioplegic solution (98). The type of solution used for graft
preservation lias been suggested to play a role in the subsequent
development of graft coronary atherosclerosis: specifically, grafts preserved
with an intracellular-type (potassium 125 mEq/L) University of Wisconsin
solution were more susceptible to developing accelerated atherosclerosis
over a 36-month follow-up period than those preserved in extracellular-type
(potassium 30 mEq/L) Stanford solution (99).
As previously rnentioned, there is a four-step sequence of potentially
damaging events on the endothelium in hearts undergoing the transplantation
procedure: (1) donor arrest, (2) cold storage, (3) warm ischemic arrest
associated with implantation, (4) reperfusion (100). Two types of solutions
have traditionally been used to preserve the allograft. The first solution is
used as a flush-out and storage medium during steps 1 through 3 and the
second serves as reperftisate at the onset of step 4. There are limitations
however to the approaches currently used to preserve cardiac allografts. The
first solution used is normalÏy based on the principles of myocardial
preservation that have been developed for cardiac procedures such as
coronary artery bypass surgery. An example is the use of St- Thomas’
Hospital cardioplegic solution as a storage medium. This approacli is flot
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necessarily hannful for the allografi but does flot take into account the
specificities of the allografi compared to hearts subjected to a single
crossclamp period during bypass surgery. These specificities include longer
period of ischemic injury, a greater degree of cooling during arrest, and the
potential for myocardial injury before harvesting by underlying cerebral
injury. The second type of solution utilizes the principles ofpreservation that
have been developed for transplantation of abdominal organs. This is
illustrated by the use of solutions such as Euro-Collins and University of
Wisconsin (UW) in heart transplant recipients. These solutions have yielded
good results but their use does flot meet the specificities of an
ischernic/reperfused myocardiurn. Differences between the heart and other
organs relates to cation transport (101), membrane permeability to different
solutes (102,103), and defense mechanisms against oxygen free radicals
(104). A solution which is effective for storage may flot be suitable for
perfusion during initial arrest (1 05,106) or subsequent cardiopÏegia given
afier reimplantation (107).
These considerations have led Menasché and colleagues (10$) to
develop an original preservation solution called Celsior which meets the
requirernents for heart transplantation (Table Ï). Celsior combines the
principles of organ preservation and allows cold storage specific for
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ischemic/reperfused myocardium and permits a single solution to be used
throughout ail phases of the transplantation procedure. Celsior is a high
sodium, iow potassium solution which uses glutamate as an energy
substrate. II is an extracellular-type solution with considerable antioxidant
properties due to its high content in reduced glutathione, which confers
superior preservation of myocardial function by preventing production of
free radicals during preservation and reperfusion (105-107, 109). The
prevention of free radical injury is achieved by the combination of three
components: reduced glutathione, mannitol, and histidine. The decrease in
production of active oxygen species, which are known to degrade NO, could
improve protection of endotheliurn-derived NO, which exerts a reguiatory
and protective role on the vascular wall. Celsior also bas the ability to
prevent cellular swelling by the combination of lactobionate (a chelator of
Fe2+ ion) and mannitol, giving it a concentration of 140 mrnol/L to
counterbalance intracellular osmotically active molecules. Experimentally,
hearts arrested and stored in Celsior were found to incur significantly
smalÏer losses of compliance afler ischemia and greater contractile function
during reperfusion compared to hearts exposed to St-Thomas’ Hospital
solution (10$). Another study showed that hearts stored in Celsior for $
hours at 4°C and reperfused retrogradely in a Langendorff model for 60
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minutes had a better lefi ventricular developped pressure than those stored in
St-Thornas’ Hospital, University of Wisconsin (UW), and rnodified (lower
potassium concentration) UW (110). Celsior was also found to significantly
better preserve high energy phosphate levels and myocardial pH versus UW
in canine hearts after 12 hour cold storage with a superior preservation of
glycogen granules at histology (111). Wamecke et al recently published a
report comparing the UW solution to Celsior in a porcine allogeneic heart
transplantation model with measurernent of right ventricular function (RV)
(112). In this study, myocardial preservation with CeÏsior solution resulted
in significantly better post-ischemic RV function than the UW solution afier
transplantation (112). In addition endothelial celis incubated for 6 or 24
hours at 4°C with Celsior or UW solutions were significantly better
preserved in terms of their viability and proliferative capability cornpared to
those incubated in Euro-Collins or St-Thomas solutions (113). Endothelium
dependent relaxations to acetylcholine were also significantly more impaired
in segments of proximal and distal coronary arteries perfused and incubated
for 15 hours in Plegisol solution compared to Celsior (114) in an in vitro
isolated rat heart model. Clinical efficacy studies are currently underway in
Europe and North America (114). Resuits of a prospective multicenter study
evaluating the Celsior solution for cardiac preservation showed an operative
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mortality of 8.6% and a 5-year actuarial survival rate of 75%, comparing
favorably with the international standards set for heart transplantation (114).
Atrial fibrillation and heart block rates were also very low in this cohort,
suggesting a role for Celsior in preserving cardiac sinus rhythrn (114).
As noted above, there is evidence that early development of
endothelial vasomotor dysfunction predicts the subsequent development of
cardiac allografi vasculopathy at 1 year post-transplant (115). The first study
presented in this memoir suggests that storage with the Celsior solution
better preserves endothelial function in cardiac allografts before
reimplantation when compared with a saline solution. The effects of the
Celsior solution on endothelium-dependent and independent relaxations
early (1 rnonth) after cardiac transplantation had not been evaluated.
Therefore, the second study presented in this memoir examines the effects of
Celsior, blood and crystalloid cardioplegic solutions on endothelium
dependent and independent relaxations in porcine coronary arteries 30 days
afier transplantation in a porcine heterotopic retroperitoneal transplantation
model to demonstrate a potential protective role of Celsior on the
endothelium and the development of intimal hyperpiasia at a distance in time
from graft implantation.
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Article #1:
Improved Preservation of Coronary Endothelial
Function with Celsior Compared witli Blood ami
Crystalloid Solutions in ileart Transplantation
E. Dumont, L.P. Perrault, O. Malo, M. Pellerin, M. Carrier
Montreal Heart Institute, Montreal, Canada
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Background: Endothelial injury from preservation solutions has been
irnplicated in acute coronary vasospasm and pathologie activation of the
endothelium, which can contribute to the development of graft coronary
vasculopathy after heart transplantation. Preservation solutions with
powerful antioxidant capacity may decrease the occurrence of these
complications. This study was designed to evaluate the effects ofCelsior (an
antioxidant solution specifically designed for cardiac preservation) in a
model of heart preservation (4 hours to mimic clinical conditions) cornpared
to two cornmonly used cardioplegic and preservation strategies on coronary
artery endothelial function in a porcine model.
Methods: Pig hearts were either imrnediately explanted and preserved
(control) or subjected to crystalloid, blood, or Celsior cardioplegia foÏlowed
by 4-hour preservation in either saline or Celsior solutions at 4°C (seven
experimental groups). Endothelium-dependent relaxation of normal porcine
epicardial coronary arteries to serotonin (5-HT, an agonist that activates 5-
HT 1 d receptors coupled to Gi proteins) and bradykinin (BK, which activates
B2 receptors coupled to Gq proteins) was studied in standard organ chamber
experiments.
Resuits: Cardioplegia with blood, crystalloid, and Celsior solutions caused
statistically significant decreases in endothelium-dependent relaxations to 5-
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HT and BK cornpared to controls. Arteries submitted to cardioplegia and
preservation demonstrated significantly decreased relaxations to 5-HT
compared with the control group except the Celsior + Celsior group.
Endothelium-dependent relaxations to bradykinin were unaltered in ail
groups afier a 4-hour storage period irrespective of preservation solution
used except in one group.
Conclusion : Cardioplegia alone caused a decrease in endothelium
dependent relaxations to Gi and Gq-protein coupled agonists. Celsior
cardioplegia and storage allowed functional recovery of endothelium
dependent relaxations to serotonin cornpared to saline preservation. The
observed effect could improve both short- and long-term outcorne in heart
transplantation.
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Introduction
Heart transplantation is the preferTed treatrnent of rnedically
unresponsive terminal cardiac failure but rernains associated with a 5-year
survival rate of 70% because of the developrnent of graft coronary
vasculopathy which leads to suent infarcts, graft failure, and sudden death
with no efficacious treatment currently available (1-3). Coronary endothelial
dysfunction precedes the development of atherosclerosis in many vascular
conditions such as diabetes mellitus, hypercholesterolemia and is predictive
in hurnan transplant recipients of the developrnent of intimal hyperplasia and
of adverse outcornes (4). Nurnerous factors may trigger the endothelial
dysfunction (5,6) afier transplantation including cellular and humoral
rejection, hyperlipidemia, cytomegalovirus reactivation, the toxic effects of
cyclosporin. The process of transplantation itself with exposure of coronary
arteries to cardioplegic solutions (7), cold ischernia (8), preservation
solutions (9), and reperfusion afier implantation (10-12) may cause
pathological activation (13) of the endothelium rendering it dysfunctional.
Endothelial dysfunction is associated with an attendant loss of the
endothelial celis regulatory and protective properties on the homeostasis of
the vascular wall which is achieved, under normal conditions, by the release
of endothelium-derived relaxing factors (EDRF) such as nitric oxide (NO),
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prostacyclin (PGI2) and the endothelium-derived hyperpolarizing factor
(EDHF). Under pathological conditions, the endothelium may also release
endotheliurn-derived constricting factors (EDCF) such as the superoxide
anion (Q2.), endoperoxydes, thromboxane A2 and endothelin- 1 which may
contribute to the developrnent of atherosclerosis by inactivating EDRFs or
by a direct effect on the vascular wall. Ischernia and reperfusion lead to the
production of ftee radicals which can scavenge endotheÏiurn-derived NO and
induce a coronary endothelial dysfunction rnanifested by reduced dilatory
responses to endothelium-dependent agonists (14).
Preservation solutions could prevent endothelial ceils from injury due to
oxygen derived free radicals during the ischernic period. Nilison et al.
showed that preservation for 5 hours in a crystalloid solution caused a
reversible acute endothelial dysfunction while no alterations were detected
when hypothermic blood cardioplegia was used (15). The type of solution
used for graft preservation has been incriminated in the causation of a higher
incidence of graft coronary atherosclerosis: specifically, grafis preserved in
the intracellular type University of Wisconsin solution were more
susceptible to developing accelerated atherosclerosis than those preserved in
the extracellular type Stanford solution (16). Moreover, a link has been
established between the severity of perioperative ischemic damage, the
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duration of cold ischernia and the subsequent developrnent of graft coronary
vasculopathy (17,1 8).
There is substantial experimental evidence which shows that oxygen
derived free radicals contribute to earÏy postoperative failure of cardiac
allografts. The Celsior solution (Pasteur-Mérieux, Lyon, France) is an
original preservation solution specifically designed for prolonged heart
preservation (Table 1). It combines the general principles of preservation
solutions as well as aspects specific to the heart such as prevention of the
development of ischernic contracture and dysfunction due to ederna. It is an
extracellular type solution with a great antioxidant capacity due to its high
content in reduced glutathion which confers a superior preservation of
myocardial function by preventing production of free radicals during
preservation and at the time of reperfusion (15,22-24). The Celsior
formulation was developed with two main principles in mmd: first, the
prevention of cellular swelling which is achieved by the combination of
lactobionate (a chelator of Fe ion, implicated in the Findel reaction) and
mannitol (which has a smaller antioxidant effect by scavenging 0 singlet)
which has a concentration of 140 mrnol/L to counterbalance intracellular
osmotically active molecules. The second guiding principle is the protection
from free radical injury which is achieved by the combination of three
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components: reduced glutathion, mannitol and histidine. These effects on
reactive oxygen species production, which are known to degrade NO, could
improve preservation of endotheÏial-derived NO. Celsior was found to be
effective in vitro in an isolated rat heart model and in vivo in a rabbit
heterotopic heart transplantation model (25). Clinical efficacy studies are
currently underway in Europe and North Arnerica, but the effects of Celsior
on endothelial function and on the developrnent of grafi vasculopathy are
unknown.
This study was designed to investigate the effect of cardioplegia and
prolonged hypothermie storage with Celsior, blood or a crystalloid solution
(KC1 60 mEq added in) followed by 4 hours ofpreservation at 40 C in saline
(NaC1 0.9%) or Celsior solutions, on the endothelial function of porcine
epicardial coronary arteries.
Materials ami Metliods
A. Animais and Experirnental Groups
Forty Landrace piglets with a mean weight of 20.2 ± 2.0 kg (range
14.0 to 22.2 kg), age 10 + 1 weeks, were used for investigating the effects of
arrest and storage with different solutions on coronary artery endothelial
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function. Ten groups were studied (Table 2): hearts in the control group
were submitted to immediate excision without administration ofcardioplegia
nor preservation (Group 1); three groups had cardioplegia with either Celsior
(Group 2), blood (Group 3), or crystalloid (Group 4) solutions without
preservation; two groups had cardioplegia induced with a crystalloid
solution and were then stored for 4 hours in a saline solution (0.9% NaC1)
(Group 5) or 4 hours in Celsior solution (Group 6) (4°C); two groups had
cardioplegia induced with normothermic blood cardioplegia (37 C) and were
then stored for 4 hours in saline solution (Group 7), or 4 hours in Celsior
solution (Group 8); finally two groups underwent cardiopiegia with Ceisior
and were stored in either saline (Group 9) or Celsior solutions (Group 10)
for 4 hours. Ail animais received humane care in cornpiiance with the
recommendations ofthe guidelines on the care and use oflaboratory animais
issued by the Canadian Councii on Animais and Guidelines ofAnimai Caret,
and were approved by a local committee.
B. Anesthesia and Surgical Technique
Anesthesia was induced with an intramuscuiar mixture injection of
ketamine (20 mg/kg; Rogarsetic, Montreal, Quebec, Canada) and xylazine
(2rng/kg; Rompun, Etobicoke, Ontario, Canada). Swines were artificially
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ventilated with an 02/air mixture (3:2). Respiratory control was maintained
by frequent determinations of arterial blood gases and acidosis was balanced
with 8.4% sodium bicarbonate (Abbott laboratories, Montreal, Que.,
Canada). Light anaesthesia was supported by halothane 1% (halocarbon
laboratories, Markham, NJ, USA). Hair was shaved at the operative field
and the skin was surgically disinfected. A median stemotorny and
pericardial incision was performed, and heparin (3 mg/kg, heparin sodium;
Leo laboratories, Kingston, Ont., Canada) was given through a central
venous catheter. The distal right innominate arteiy was ligated and the
proximal portion cannulated with a polyvinyl chloride catheter positioned in
the ascending aorta for administration ofcardioplegia. Afler clamping ofthe
aortic arch between the two innorninate arteries, asystole was induced
through injection of the cardioplegia solution in the ascending aorta at a
maximal pressure of 60 mm Hg. The heart was vented by incision of the
right and left atrial appendages and the heart was excised.
C. Cardioplegia and Storage Period
In the control group, the hearts were irnmediately excised and transferred
to organ chambers. The cardioplegic solutions used were crystalloid (12
mL/kg), Celsior (12 mL/kg) or normothermic blood (4:1 blood-Ringer’s
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lactate ratio 15 mL/kg). In the normothermic blood group, blood was
harvested during the initial phase of anaesthesia in a 450 mL bag with 63
mL citrate dextrose phosphate and kept normothermic. Potassium chloride
(mean 60 mEq) was then added through a Y-tubing in the crystalloid, blood
and Celsior solution groups and administered in the aortic root. Afier
ftooding ofthe pericardium with cold storage solution, the heart was excised
and placed in the designated storage solution for 4 hours at 40 C or
transferred to organ chambers as described above.
D. Vascular Reactivity
The lefi anterior descending, left circumilex and the right coronary
arteries were excised from the myocardium and dissected free from the
epicardium, rnyocardium and from adventitial tissue and divided in 4 mm
wide rings and used randornly in organ chamber experirnents. Sixteen rings
were used for each animal, eight rings per endothelium-dependent agonists
(5-HT and BK).
The endothelial function of control and arteries rings submitted to
cardioplegia and storage was studied in organ chambers fflled with Krebs
bicarbonate solution (20 mL at 37° C: composition in mmol/L: NaCY 118.3,
KCÏ 4.7, MgSO4 1.2, KH7PO4 1.2, glucose 11.1, CaCl2 2.5, NaHCO3 25 and
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calcium ethylenediaminotetraacetic acid 0.026). Oxygenation was insured
using a 95% 02 / 5% C02 gas mixture. The rings were suspend between two
metal stirrups, one of which was connected to an isometric force transducer.
Data were collected with a data acquisition software (10S3, Emka Inc.,
Paris, France).
Ail studies were performed in the presence of indomethacin (1 0 mol/L,
to exciude the production of endogenous prostanoids), propranolol (1 0
rnol/L, to prevent the activation of f3-adrenergic receptors), and ketanserin
(incubated 45 minutes before the addition ofserotonin: 106 mol/L, to block
serotonin 5HT-2 receptors which cause contraction of smooth muscle ceils
in the absence of ketanserin). Each preparation was stretched to the point of
its active length curve (usually 3.5 g), as determined by measuring the
contraction to potassium chloride (30 mrnol/L) at different levels of stretch,
and then stabilised for 30 minutes. The maximal contraction was
determined with potassium chloride (60 mmol/L) and rings were excluded if
they failed to contract to potassium chloride (exclusion rate less than 5%).
After washing and 45 minutes of stabilisation, prostaglandin F2Œ (range, 2 X
1 OE6 to 1 0 mol/L) was added to achieve a contraction averaging 50% of the
maximal contraction to KCÏ (60 mmol/L). Endothelium-dependent
relaxations to serotonin (5-HT, i0’° to i0 mol/L, an agonist which
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activates 5HTJd receptors coupled to Gi-proteins which lead to the release of
NO) and bradykinin (BK, 1O2 to 106 mol/L which activates B2 receptor
coupled to Gq-proteins which lead to the release of NO and EDHF) were
rneasured. At the end of the experirnents, endothelium-independent
relaxations were studied using a single bolus of sodium nitroprusside (SNP
iO rnol/L, a nitric oxide donor). No rings were exposed to more than one
endothelium-dependent agonist.
E. Drugs
Ail solutions were prepared daily. Bradykinin, 5-Hydroxytryptamine
creatinin sulfate (serotonin), indomethacin, ketanserin and sodium
nitroprusside were purchased from Sigma Chemical Co. (Oakville, Ontario,
Canada). Propranolol was purchased from Biomol Research Laboratories
Inc. (Plyrnouth Meeting, PA, USA) and prostaglandin F2Œ was purchased
from Cayman Chemical Company (Ann Arbor, MI, USA).
F. Statistical analysis
Contractions to PGF2Œ are expressed as the percentage ofthe maximal
contraction to potassium chloride (60 mmol/L) for each group and expressed
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as means ± standard error of the mean (SEM); an” refers to the number of
animais studied. Relaxations are expressed as percentage of the maximal
contraction to PGF2Œ for each ring. ANOVA studies were performed to
compare dose-response curves. Differences were considered to be statistically
significant when the value ofp < 0.05.
Resuits
A. Vascular Reactivity
Contractions
There were statistically significant differences in the amplitude of the
contraction to potassium chloride (60 mmol/L) between the
crystalloid/Celsior cardioplegia groups and the control/blood groups. There
were also statistically significant differences in the amplitude of the
contraction to potassium chloride (60 rnmol/L) among the groups, except in
arteries subrnitted to cardioplegic arrest with Celsior and preservation in
saline (group 6) which showed a significant decrease (f igure 1). There were
no statistically significant difference in contractions to PGF2Œ (range
2 i o6 to 1 0 mol/L ) except in the group subrnitted to cardioplegic arrest
with Celsior and preservation in the saline solution (group 6) which showed
a significant increase ($8.1 ± 4.3%,p < 0.05 vs all groups) (Figure 2).
44
Relaxations
$erotonin. There were no significant difference in endothelium-dependent
relaxation to serotonin and bradykinin between arteries submitted to storage in
saline only (group 1) versus normal porcine coronary arteries freshly explanted
and tested (data not shown).
There was a statistically significant decrease in endothelium-dependent
relaxations to serotonin in porcine coronary arteries submitted to crystalloid,
blood, or Celsior cardioplegia alone (Groups 2-4) (Figure 3).
There were no statistically significant decreases of endothelium-dependent
relaxations to serotonin in the Celsior cardioplegia + Celsior preservation
group (group 10) compared with controls. When the Celsior and crystalloid
solutions were used for cardioplegia , the arteries subsequently preserved in
Celsior (group 6 and 10) showed a significantly superior preservation of
relaxation to 5-HT compared to those preserved in saline (p <0.05 for Celsior
+ Celsior group vs Celsior + Saline only) (Figure 4). There was a statisticaliy
significant decrease in endothelium-dependent relaxations to serotonin in
arteries from ail other cardioplegic/preservation groups (groups 5,6,7,8,9)
compared with controls (Figure 4).
Bradykinin. There was a statistically significant decrease of endothelium
dependent relaxations to bradykinin in rings from ail coronary arteries exposed
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to either blood, crystalloid, or Celsior cardioplegia alone (figure 3). There was
a statistically significant decrease of endothelium-dependent relaxations to
bradykinin in rings from the Blood + Celsior and Celsior + Saline groups
(groups 8 and 9) at one concentration ( 3 x 10 rnol/L) (p <0.05 vs control
group). There were no statistically significant differences between ail other
four cardioplegic/storage groups compared with controls (figure 5).
Endothetium-independent reÏaxations. There were no statistically significant
differences in the maximal relaxation to sodium nitroprusside (SNP;
i0 mol/L) in ail groups (data not shown).
Discussion
The major findings of this study are that exposure of porcine coronary
arteries to cardioplegic arrest with crystalloid, blood or Celsior cardioplegic
solutions cause a significant decrease in endothelium-dependent relaxations to
serotonin and bradykinin. Subsequent preservation in saline does flot provide
recovery of endothelium-dependent relaxations. Induction of arrest and
preservation with Celsior allows for functional recovery of endothelium
dependent relaxations to both serotonin and bradykinin and thus beller
preserves the endothelial function of coronary arteries under the present
experimental conditions.
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Endothelium-dependent contractions
The significant decrease in the amplitude of contraction to potassium chloride
in the arteries submitted to cardioplegia with Celsior and saline preseiwation
may be related to the greater potassium loading or decreased sensitivity to
exogenous potassium in this group although it was not observed in the other
groups in which Celsior was used for cardiopiegia. The greater amplitude of
contraction to prostaglandin F2Œ in the arteries subrnitted to Celsior
cardioplegia and saline preservation may reflect a greater sensitivity of the
vascular srnooth muscle ceil to exogenous prostaglandins. Under certain
conditions, endothelium-dependent contractions can be explained either by
the withdrawai of the release of endotheliurn-derived relaxing factors (NO,
prostacyciin) or by the production of diffusibie vasoconstrictor substances
coined endotheiiurn-derived contracting factors (EDCF).
Effect of the cardioplegic solution
Perfusion of coronary arteries with the crystalloid, blood, and Celsior
cardiopiegic solutions ail caused a decrease in endothelium-dependent
relaxations to serotonin and bradykinin. Perfusion of coronary arteries with
the crystalloid and blood solutions followed by preseiwation in either saline or
Celsior to obtain an electrornechanical silence induces a decrease in Gi
protein-mediated relaxations. Perfusion of Celsior for cardioplegic arrest
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followed by preservation in saline also causes a sirnilar type of dysfunction.
This endothelial dysfunction preferentially involves Gi- protein mediated
relaxations as demonstrated by reduced responses to serotonin which acts by
binding to 5-HTID receptors coupled to Gi-proteins in normal porcine coronary
arteries. The Gq-protein rnediated relaxations are altered to a lesser degree as
evidenced by preservation of relaxations to bradykinin (which binds to B2
receptors coupled to Gq-proteins and leads to the release of NO and EDHF in
normal porcine coronary arteries) except at one concentration in the group
submitted to crystalloid cardioplegia with storage in the saline solution. The
G• protein mediated pathway is one of the first pathways affected in many
cardiovascular diseases such as acute and chronic cardiac rejection (19,26),
atherosclerosis (27,28) and may be an early marker ofpathological endothelial
activation implicated in the developrnent ofvascular diseases. Preservation of
this sensitive endothelial celi signaling pathway, reflecting the final capacity of
the vascular wall to produce the vascular protector endothelial NO is important
to avoid progression to a generalized endothelial dysfunction associated with
advanced atherosclerosis. Endothelium-dependent relaxations rnediated by the
NO donor, sodium nitropmsside, were unaffected, therefore demonstrating the
integrity of vascular smooth muscle cells. This confirms that the reduction of
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vascular relaxation observed throughout the groups studied is due to
endothelium-dependent mechanisrns.
Perfusion of coronaries with a crystalloid solution is known to alter
endothelium-dependent relaxations in comparison to perfused controï (29)
without any morphological alterations of endothelial cells. Cardioplegia with
St-Thomas solution delivered at 60 to 65 mm Hg significantly reduces
endothelium-dependent relaxations in addition to the cold ischemic period and
reperfusion (30). However, others have shown that use of a hyperkalernic
crystalÏoid cardioplegic solution does not irreversibly alter endothelium
dependent relaxations to acetylcholine (G-protein rnediated) or adenosine
diphosphate (ADP) (31). Perfusion at a pressure of 240 cm H20 impairs the
vasodilatory response to serotonin and results in vasoconstriction (32). These
studies suggest that the dysfunction observed are due to a traurnatic effect of
baroreceptors or to shear stress on the vascular wall ofthe artery and not from
the cardioplegia solution itself. He et al. demonstrated that the relaxation to
EDHF is altered following exposure to a hyperkalemic solution due to partial
membrane depolarisation of the srnooth muscle cells affecting the potassium
channels and the release of the endotheliurn-derived relaxing factors (34,35).
Although Celsior is sufficient in itself to induce cardioplegic arrest,
potassium was added in the Y-tubing as with the two other cardioplegic
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solutions to negate the confounding effect of hyperkaliemia on the induction
ofcoronary endothelial dysfunction in this mode!.
Effect of the storage so]ution
The preservation times currently considered safe range between 4 to 6 hours
and longer ischernic periods are associated with a reduction ofthe survival rate
of heart transplant recipients (35). Storage at 40 C was superior in preserving
the endothelial and myocardial function cornpared to 200 C in an iso!ated heart
model in rats (36). Accordingly, porcine coronary arteries exposed to 4 hours
of storage at 40 C dernonstrated similar endothelium-dependent relaxations
compared with fresh!y harvested arteries. This strongly suggests that the
endothelial dysfunction observed in the groups exposed to cardioplegia
solutions is not a consequence of preservation but a resu!t of perfusion of the
coronary arteries during cardiac arrest (37). The preservation time of 4 hours
in this study was chosen since it represents the average ischemic tirne in a
clinica! heart transplantation setting.
Storage of the heart in a saline solution does flot alÏow recoveiy of Gi
protein mediated relaxations during the 4 hour storage period as shown by the
decrease relaxations to serotonin in the cardioplegia groups stored in saline.
Storage in the Celsior solution was associated with a better preservation ofGi
protein mediated relaxations except in the group in which blood was used as
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the cardioplegic solution which showed a significant endothelial dysfunction.
The fact that storage in saline after Celsior cardioplegia allowed for recovery
of endothelial function to Gq-protein mediated relaxations can be explained in
a twofold maimer. Firstly, it is highly likely that endothelial dysfunction seen
in ail three groups afler cardioplegia alone was due to shear forces and
barotrauma and not to the cardioplegic solution itseif It is known that infusion
of a hyperkalemic crystalloid cardioplegic solution does flot alter the
endothelium in a irreversible manner (31) and thus the 4 hours of preservation
in saline could have allowed for functional recovery of the endothelium in the
more resistant Gq-protein rnediated pathway. Secondly, the Celsior
cardioplegic solution rnight cause initial dysfunction but may aÏlow a better
recovery ofendothelial function regardless ofthe preseiwation solution used by
its beneficial properties likely related to its antioxydant capacity to eliminate
free radicals production during ischemia combined to a reduction of
myocardial oedema (25). Use of this new preservation solution could protect
grafis from the deleterious effects of preservation (38) as suggested by a
clinical study in which use of Celsior was associated with an increased
inotropic and vasodilatory response in transplanted patients in contrast to the
University of Wisconsin solution (39). This is consistent with the observation
that the superior arrest and storage strategy under the present experimental
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conditions is use of Celsior for induction of cardioplegia and storage in
Celsior. Indeed, endothelium-dependent relaxations of coronary arteries
exposed to cardioplegia and preservation with Celsior solution are sirnilar to
the control group. Storage of the heart for 24 hours in a crystalloid solution
with the antioxydant indonoindole also preserves endothelium-dependent
relaxations in comparison to crystalloid alone (40) suggesting that
improvernent in the formulation of preservation solutions may lengthen the
safe ischemic tirne for heart transplantation. Lung preservation, using Celsior,
(41,42) has also yielded favorable initial results.
Limitations
Damage by production of free radicals by leukocytes at the tirne of
reperfusion is a significant contributing factor in the developrnent of
pathological activation of the endothelium (14). The present study solely
addresses the effects of arrest and preservation solutions on coronary
endothelial function. Further studies evaluating the consequences of
myocardial reperfusion following storage on coronary endothelial function
are needed since the endothelial dysfunction observed with arrest and
storage are likely to be compounded by reperfusion. The benefits of using
Celsior may become even more evident considering its proven capacity for
capture of oxygen derived ftee radicals occurring during reperfusion. Use of
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normal swine does flot reftect the clinical condition of organ harvest
associated with brain death which may be associated with massive
cathecolamines release and functional disturbances depending on the
rnechanism of death. Experimental studies evaluating the effects of this
condition on rnyocardial and coronary endothelial function may yield further
insight on the problematic of solid organ procurernent and storage. Finally,
studies of the effects of preservation solutions and storage on coronary
microvascular function should also be undertaken considering the central
role ofthe microcirculation in autoregulation of coronary blood flow.
Conclusion
In summary, cardioplegic arrest and storage with Celsior constitutes the best
strategy permitting the preservation of endothelium-dependent relaxation in
porcine epicardial coronary arteries. $uperior preservation of coronary
endothelial function at the time of implantation may reduce early grafi
failure by improving coronary blood flow and limit the development of graft
coronary vasculopathy by maintaining the protective effects of the
endothelium on the vascular wall.
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Figures ami Tables Legend
Table 1: Composition and characteristics of Celsior solution.
Tab]e 2: Experimental groups.
Figure 1: Amplitude of contractions to potassium chloride (60 mmol/liter).
*p<005 vs control.
Figure 2: Amplitude of contractions to PGF2Œ (range 2 X 10-6 to 10-5
mol/liter) *p<0 05 vs control.
Figure 3: Concentration-response curve to serotonin (5-HT) (a) and
bradykinin (b) of porcine epicardial coronary arteries after crystalloid
cardioplegia, blood cardioplegia, and Celsior cardioplegia. *p<O.05 vs
control.
Figure 4: Concentration-response curve to serotonin (5-HT) of porcine
epicardial coronary arteries after crystalloid cardioplegia (a), blood
cardioplegia (b), and Celsior cardioplegia (c) and subsequent preservation.
*p<005 vs control.
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Figure 5: Concentration-response curve to bradykinin (BK) of porcine
epicardial coronary arteries afier crystalloid cardioplegia ta), blood
cardiolegia (b), and Celsior cardioplegia (c) and subsequent preservation.
*p<005 vs control.
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Article #2:
Protective effects of Celsior on coronary
endothelial function one month after
transplantation in a porcine model.
Eric Dumont, IVID, Olivier Malo, MSc, Michel Pellerin, MD, Michel Carrier,
MD, Louis P. Perrault, MD, PhD
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ABSTRACT
Background: The development of coronary allograft vasculopathy is
preceded by endothelial dysfunction leading to abnorrnal vascular response
to agonists. Endothelial injury from preservation solutions used at the time
of organ harvesting has been implicated in acute coronary vasospasm and
pathologic activation ofthe endothelium. The present study was designed to
examine the potential protective effects of Celsior, a new preservation
solution specifically designed for heart transplantation, on coronary
endothelial reactivity at 1 month afier transplantation compared with
crystalloid and blood based cardioplegic solutions with saline preservation.
Methods: A porcine model of heterotopic heart transplantation was used.
Preoperative serum typing for the class I antigen of the swine lymphocyte
alloantigen was performed to ensure compatibility for this antigen which
permitted survival of the graft with a slow kinetic of rejection without
immunosuppression. Three experirnental groups were studied: Donor hearts
were arrested with hyperkalemic crystalloid, blood or Celsior cardioplegia
(12 cc/kg) and irnmediately irnplanted in the recipient. Swine were sacrificed
at 1 month and rings of epicardial coronary arteries of native (control) and
transplanted hearts were studied in organ chambers filled with rnodified
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Krebs-Ringer bicarbonate solution. Endothelium-dependent relaxations to
serotonin (5-HT, an agonist that activates 5-HTld receptors coupled to Gi
proteins), bradykinin(BK, which activates B2 receptors coupled to Gq
proteins), and calcium ionophore were assessed. Neointirnal proliferation
was evaluated using histomorphometric studies.
Resuits: There was a significant decrease in endothelium-dependent
relaxations to serotonin in ail three groups submitted to preservation
solutions versus control s. Endothelium-dependent relaxations to bradykinin
were significantiy reduced in the crystalloid group but not in the blood or
Celsior groups versus controls at 1 month. Relaxation to calcium ionophore
was significantly decreased in the three groups versus controls, and the
crystalloid group had a significant decrease in relaxation versus the blood
and Celsior groups. There was a trend towards a dirninished neointimal
proliferation in the Celsior group at 1 month.
Conclusion: The type ofcardioplegic solution used for harvesting hearts
significantly influences endothelial reactivity 1 month after transplantation.
The use of crystalloid solution causes a decrease in endothelium-dependent
relaxations to agonists as compared to blood and Celsior solutions. The use
of Celsior and blood has a protective effect on endothelial function at 1
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month which could potentially reduce the incidence of coronary allograft
vasculopathy compared to other solutions.
Introduction
Although heart transplantation remains the treatrnent of choice for
medically unresponsive terminal heart disease and is associated with a 5-
year survival of 70%, graft coronaiy vasculopathy develops in a rnajority of
transplant recipients and is the main cause of death beyond the first year
afier transplantation (1-3). The appearance of accelerated atherosclerosis
after heart transplantation is preceded by reduced dilatations of the coronary
artery to endothelium-dependent agonists, suggesting the presence of an
early endothelial dysfunction. When identified, this dysfunction is predictive
of the development of graft coronary disease one year afier grafi
implantation and of the occurrence of cardiac events and death (1). The
exact mechanisms underlying the coronary endothelial dysfunction that
occurs afler heart transplantation remain elusive. Patients studied one to five
rnonths afler grafi implantation demonstrate a selective impairment of
endothelium-dependent dilatation to acetylcholine, whiïe the dilatation to
bradykinin is maintained (4). The time course of coronary endothelial
dysfunction in acute untreated rejection is characterized by an endothelial
dysftinction initially involving Gi-protein mediated relaxations (5)
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developping beyond 5 days after heart transplantation which is due to
progressive loss of endothelial celis. The dysfunction worsens over time to
affect ail endotheliai mechanisrns and vascular srnooth muscle. Other
pathways of endothelium-dependent relaxations and vascular srnooth muscle
celi function also become affected with an increase in the duration of
rejection (6).
The nurnerous factors which may trigger endothelial dysfunction
(11,12) afier transplantation include cellular and humoral rejection,
hyperlipidemia, cytornegalovirus reactivation, and the toxic effects of
immunosuppressants such as Cyclosporin A. The process of transplantation
itseifwith exposure of coronary arteries to cardioplegic solutions (13), cold
ischemia (14), preservation solutions (1 5), and reperfusion after implantation
(16-18) may cause pathologic activation of the endothelium rendering it
dysfunctional.
A retrospective analysis in heart transplant centres in the United
Network of Organ $haring(19) showed that approximately 167 different
preservation solutions are used in heart transplantation today. The type of
solution used for cardioplegia and preservation has been suspected to play a
role in the development of subsequent graft coronary atheroscierosis:
specifically, grafis preserved in the intraceilular-type (potassium 125
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mEq/L) University of Wisconsin solution were more susceptible to
developing accelerated atherosclerosis over a 36-month follow-up period
than those preserved in extracellular-type (potassium 30 rnEq/L) $tanford
solution (20). These considerations led Menasché and coÏleagues (21) to
develop an original preservation solution called Celsior which addresses
specific issues in heart transplantation. It combines the principles of organ
preservation and allows cold storage specific for ischernic/reperfused
rnyocardium and permits a single solution to be used throughout ah phases
of the transplantation procedure. It is an extracellular type solution with a
great antioxidant capacity due to its high content in reduced glutathion
which confers a superior preservation of rnyocardial function by preventing
production of free radicals during preservation and at the time of reperfusion
(15,22-24). The Celsior formulation was developped with two main
principles in mmd: first, the prevention of cellular swelling which is
achieved by the combination of lactobionate (a chelator of Fe ion,
implicated in the Findel reaction) and mannitol (which also has a smahl
antioxidant effect by scavenging 0 singlet) which lias a concentration of
140 mrnol/L to counterbalance intracellular osmotically active molecules.
The second guiding principhe is protection from free radical injury which is
achieved by the combination of three components: reduced glutathion,
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mannitol and histidine. The protective effects on reactive oxygen species
production, known to degrade NO, could improve preservation of
endotheïiaÏ-derived NO. Celsior was found to be effective in vitro in an
isolated rat heart model and in vivo in a rabbit heterotopic heart
transplantation model (25). Clinical efficacy studies are currently underway
in Europe and North America but the effects of Celsior on endothelial
function and on the development of graft vasculopathy are unknown.
Early development of endothelial vasomotor dysfunction predicts the
subsequent deveÏoprnent of cardiac allografi vasculopathy 1 year after
transplantation (1). Preliminary studies suggest that storage with Celsior
solution preserves endothelial function in the cardiac allografi before
reimplantation. The effects of Celsior solution on endothelium dependent
and independent relaxation early (1 month) after cardiac transplantation have
flot been evaluated. This study was designed to determine whether a
protective effect on donor porcine epicardial coronary artery endothelium is
conferred by Celsior cardioplegia versus bÏood or crystaïloid solutions 30
days aller heterotopic retroperitoneal transplantation when rejection of the
vascular wall affects endothelial reactivity. A period of 30 days was used
arbitrarily to allow for early endothelial dysfunction and intimai hyperpiasia
to occur.
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Material and Methods
A. Animais and Immunologic Studies
Ail experiments were performed using Landrace piglets of either gender,
aged 15 + 2 weeks and weighing 36.6 ± 5 kg. They were conducted in
compliance with the “Guide for the care and use of Laboratory Animais”
pubÏished by the National Institute of Health (NIH publication no. $5-23,
revised 1985). Ail procedures used in this study were approved by the local
ethics committee on animal care. Preoperative blood samples were taken for
blood typing and determination of the cÏass I antigen of the Swine
Lymphocyte Alloantigen (SLA) system by the rnicrolyrnphocytotoxicity
technique. Swine from the sarne litter were used to ensure a rate of
recombination between the class I and class II regions of the major
histocornpatibiiity complex of < 1% (Institut National de Recherches
Agronomiques). The transplantations were performed between animals
compatible for blood type and for the SLA class I antigen.
B. Anesthesia
Premedication was achieved with a mixture of atropine sulfate (0.04
rng/kg) and xylazine (2 rng/kg) injected intramuscularly. Anesthesia was
supported by continuous inhalation of 1% isofluorane via orotracheal
intubation.
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Ventilatory support was established by orotracheal intubation in both
the donor and recipient swines with a cuffed tube. Ventilation was
maintained with a respirator (Mark 8, Bird Co., Paim Spr-ings, CA. USA)
with oxygen supplernentation to maintain an arterial oxygen saturation of
95%. Venous access was obtained through the right saphenous vein and
right intemal jugular vein for volume replacement with Ringer’s lactate.
Venous blood samples were taken for complete hematological and
biochemical profiles. Arterial cannulation was perforrned in the recipient
swine tbrough the right intemal carotid artery for blood pressure monitoring
and arterial gas analysis. The serum pH was rnaintained between 7.35 and
7.45 by adjustrnent of the ventilatory rate and intravenous administration of
sodium bicarbonate as needed. Antibiotic prophylaxis was provided with a
single intravenous dose of teramycine (10 rng/kg) prior to incision and
intrarnuscular injection in the post-operative period as needed.
C. Cardioplegia
Cardioplegia protocols were established according to three different
experimental groups (Table 1). In the first group (n=4), a crystalloid (15
rnEq) solution (0.9% saline solution with 15 mEq/L KCJ added) was used to
induce cardioplegic arrest in the donor via the ascending aorta at a perfusion
pressure of 60 mrnHg. In Group 2 (n8), Celsior solution was used to induce
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airest as described above and finally in Group 3 (n3), donor blood (12
cc/kg) was harvested during the initial phase of anesthesia in a 450 cc bag
with 63 cc of citrate dextrose phosphate and kept normothermic. Ringers’
Lactate (3 cc/kg) was added to the donor blood for a final blood cardioplegia
solution composition of 4:1 blood/crystalloid ratio. Potassium chloride was
then added through a Y-tubing to achieve cardioplegia (mean 12 ± 3 rnEq)
and this solution infused in the ascending aorta as described. The control
group were the native hearts harvested from the recipient at the tirne of
sacrifice.
D. Heterotopic Heart Transplantation
Donor: Afier median stemotorny and pericardial incision, the heart was
prepared by dissection and suture control without ligation ofthe superior and
inferior vena cavae, the right and left superior and inferior pulmonary veins
and the left hemi-azygous vein (which enters the coronary sinus in the
swine). Afier systemic heparinisation (3 mg/kg), the distal right innominate
artery was ligated and proximal portion cannulated with a polyvinyl chloride
catheter positioned in the ascending aorta for administration of cardioplegia.
The heart was vented by incision of the right and left atrial appendages and
the blood vessels isolated previously were ligated. After clamping of the
aortic arch between the two innominate arteries, asystole was induced
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through injection of cardioplegic solutions according to experimental groups
(Table 1) in the ascending aorta at a maximal pressure of 60 rnmHg. The
heart was vented by incision of the right and left atrial appendages and the
blood vessels controled previously were ligated. Local hypothermia was
added by flooding the pericardium with cold physiological saline solution
(4°C). Afier excision, the heart was prepared for implantation by ligation of
the atrial incisions and dissection of the adventitial tissue between the
ascending aorta and the main pulrnonary artery and placed in a cold (4°C)
solution.
Reczient: After a left subcostal transverse incision, the infrarenal
abdominal aorta and vena cava were approached retroperitoneally and
dissected free of lymphatic tissue. After systemic heparinisation (3 mg/kg),
the infrarenal aorta was clamped by application of a side clarnp. End-to-side
anastomosis was performed between the donor ascending aorta and recipient
abdominal aorta using a running suture of 5-0 polypropylene. After
clamping of the donor aorta to avoid immediate reperfusion, the side cÏamp
was released and hemostasis secured. Using the same technique, an end-to
side anastomosis was performed between the donor main pulmonary artery
and the inferior vena cava using 6-0 polypropylene. After reperfusion
(ischemic tirne 66.7 ± 15 mm), deairing was performed by needle insertion
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into the apex and left atrial decompression as needed and normal sinus
rhythm reestabiished with direct defibrillation as needed. The retroperitoneal
cavity and subcutaneous tissues were closed with a 0 vicryl suture.
E. Postoperative care
Afler standard ventilatory weaning, the animais were lefi to recover in
temperature controiled quarters and fed piglet chow and water ad libitum.
The animais were examined daiiy for signs of infection or malaise and were
given antibiotics for 5 days if wound infection or core temperature was
greater than 3 8.0°C. The recipients were sacrificed eÏectively on day 30 after
transplantation.
F. Expiantation protocol and experirnental groups
Allograft liearts: After induction of anesthesia with a mixture of
ketarnine (20 mg/kg) and xyiazine (2 mg/kg) injected intrarnuscuiarly,
venous access, volume replacement and ventilatory support were established
as described above. The abdomen was reentered and complete mobilisation
ofthe ailograft was performed taking care not to injure the epicardial surface
of the heart. The aorta and main pulrnonary artery were transected and the
allografi expÏanted and placed in a cold saline solution.
Native hearts were excised through a median stemotomy in the same
fashion and placed in a cold physiological solution.
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Exclusion criteria: Hearts were excluded if the contractility was
absent or if the coronaiy arteries were thrornbosed (n=2 at day 30).
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G. Vascular Reactivity
The native and allografi left anterior descending, circumftex, and right
coronary arteries were dissected free from the epicardium, myocardiurn, and
adventitial tissue and divided into 4 mm wide rings in a random but rnatched
fashion. Sixteen rings were used for each animal, eight rings for
endothelium-dependent agonists serotonin (5-HT) and bradykinin, and eight
rings for endothelium-dependent receptor-independent calcium ionophore
(A23 127). The endothelial function of control and allograft arteries were
studied in organ chambers fihled with Krebs bicarbonate solution (20 cc at
37°C in the following composition in rnrnol/L: NaCY 118.3, KCT 4.7, MgSO4
1.2, KH2PO4 1.2, glucose 11.1, CaCl 2.5, NaHCO3 25 and calcium
ethylene-diamine tetraacetic acid 0.026). Oxygenation was insured using a
95% 02 /5% C02 gas mixture. The rings were mounted between two metal
stirrups, one of which was connected to an isometric force tansducer. Data
were collected with a data acquisition software (10S3, Emka, Inc., Paris,
France). Ah studies were performed in the presence of indomethacin (1 0
mol/Yiter, to exclude the production of endogenous prostanoids), propranolol
(i0 mol/liter, to prevent the activation of f3-adrenergic receptors), and
ketanserin (incubated 45 minutes before the addition of serotonin: 1 0
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rnol/liter, to block serotonin 5-HT, receptors, which cause contraction of
smooth muscle celis in the absence ofketanserin).
Each preparation was stretched to the optimal point of its active
Ïength-tension curve (usually 3.5 g), as deterrnined by measuring the
contraction to potassium chloride (30 mrnol/L) at different levels of stretch,
and then stabilized for 30 minutes. The maximal contraction was determined
with potassium chloride (60 mrnol/L) and rings were excluded if they failed
to contract.
Afier washing and 45 minutes stabilization, prostaglandin F2u (range
2 X 1 06 to 1 0 mol/L) was added to achieve a contraction averaging 50% of
the maximal contraction to KC1. Endothelium-dependent relaxations to
serotonin (5-HT; 10d0 to 10 mol/L, an agonist that activates 5-HT1d
receptors coupled to Gi proteins, leading to an increase in NO), bradykinin
(BK; 1012 to 106 mrnol/L an agonist that activates B2 receptors coupled to
Gq proteins, leading to the production of NO and EDHF), and calcium
ionophore (A23 187; 1 0 to 1 0 mol/L an endothelium-dependent receptor
independent agonist, which leads to the release of NO, were compared
between native, the three allograft groups, and control coronary rings at 30
days after transplantation. At the end of the organ chamber protocol,
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endothelium-independent relaxations were studied using a single bolus of
sodium nitroprussiate (SNP; 10-5 mol/L, a NO donor).
H. Morphometric Analysis
After each organ chamber experiments, coronary rings were fixed in
10% formaldehyde for 20 minutes at their optimal tension. Ail formaiin
fixed tissue sections were ernbedded in paraffin, and five micron sections
were stained with orcein. Each section was examined for the presence,
extent, and distribution of intimal thickening, luminai narrowing, and
inftammatory infiltrates. Histomorphometric studies were performed to
evaluate the intima to media surface ratio by light microscopy. Abnormal
intimai hyperplasia was associated with an intima to media surface ratio
greater than 5%. Ah histological studies were read in a blinded fashion by an
independent observer.
I. Myocardial biopsies and grading ofrejection
Surgical myocardial biopsies of allografts and native hearts were taken
from the septum, the right and left ventricles of fresh specimens at the time
of explantation in ahlografts and native hearts and fixed in formaldehyde
(10%). Hematoxylin eosin-safran staining was performed and the biopsies
evaluated for rejection grade, extent ofnecrosis and ischemic times.
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J. Drugs
Ail solutions were prepared daily. Bradykinin, 5-hydroxytryptamine
creatinine sulfate (serotonin), calcium ionophore A23 187, indomethacin,
ketanserin, and sodium nitroprussiate were purchased from Sigma Chemical
Co. (Oakville, Ontario, Canada). Propranolol was purchased from Biornol
Research Laboratories, Inc. (Plymouth Meeting, PA) and prostaglandin F2Œ
was purchased from Cayman Chemical Co. (Ann Arbor, MI).
K. Statistical analysis
Contractions to PGF2Œ are given as a percentage of the maximal
contraction to potassium chloride (60 mmol/L) for each group and expressed
as mean ± SEM; n refers to the number of animais studied. Relaxations are
expressed as percentage of the maximal contraction to PGF2Œ for each ring.
Analysis of variance (ANOVA) studies were perforrned to compare dose
response curves and differences considered statistically significant at
p’<0.05. $tudent’s t-test for paired/unpaired observations was used for
statistical analysis in the comparison of the incidence of intimai hyperplasia
between different experimental groups and controls.
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RESULTS
Vascu]ar Reactivity
Contraction: There were no statistically significant differences in
amplitude of contraction to potassium chloride (60 rnmol/L) between the
different groups (data flot shown). There were no statistically significant
differences in contraction to PGF2u (range 2 X 10-6 to 10-5 mol/L) between
ail groups (data flot shown).
Endothelium-Dependent Relaxations
Serotonin. There was a statistically significant decrease in
endothelium-dependent relaxation to serotonin in the crystalloid, blood, and
Celsior cardioplegia groups versus native coronary arteries 1 month after
transplantation (Figure 1). There were no significant differences in
relaxation between the different study groups.
Bradykinin. There was a statistically significant decrease in
endothelium-dependent relaxation to bradykinin in the crystalloid versus the
native group 1 month afier transplantation. No significant difference in
endothelium-dependent relaxation was observed in the blood and Celsior
cardioplegia groups versus at 1 rnonth (Figure 2).
Calcium Ionophore. There was a statistically significant decrease in
endothelium-dependent relaxation to the calcium ionophore in the
$1
crystalloid versus ail other groups in coronary arteries 1 month afler
transplantation. There was also a statistically significant decrease in
endothelium-dependent relaxation to calcium ionophore in the crystalloid,
blood, and Celsior groups versus controls (Figure 3).
Endothelium-Independent Relaxations
There were no statistically significant differences in maximal relaxation to
sodium nitroprussiate (SNP) (10-5 mol/L) among the groups (data not
shown).
Myocardial biopsies
The myocardium from native hearts was normal. Allografted hearts thirty
days afler implantation showed extensive Yymphocytic infiltration with
prominent fibrosis and moderate to severe arnount ofnecrosis ail compatible
with the ISHLT classification grade 3B rejection. There were no significant
differences in the rejection grade between ail three experimental groups.
Histomorphometric Studies
There were no significant differences in the intima to media ratio between
the three cardioplegia groups and controis. There was a trend for the native
arteries and the Ceisior groups to have iess intimai hyperplasia than the
biood and crystalloid groups but this did not reach statisticai significance.
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DISCUSSION
The major findings of this study are that 1) exposure of porcine
coronary arteries to cardioplegic aiiest with Celsior or sanguineous solutions
before heterotopic heart transplantation better preserves endothelial
reactivity of epicardiai coronary arteries at 30 days under the present
experirnental conditions cornpared to crystalloid solution. 2) All three
cardioplegic solutions studied induce a significant decrease of endothelium
dependent relaxations to serotonin 30 days afler transplantation.
Crystalioid cardioplegia induce a generaiized endothelial dysfunction to ail
three agonists and is cleariy the most detrimental to the endothelium. There
were no significant differences in intimai hyperplasia between experimental
and control groups at 30 days.
The type of cardioplegic solution used for grafi harvesting has been
suggested to play a role in the development of subsequent graft coronary
atherosclerosis (18). Celsior combines the principles of organ preservation
and allows cold storage specific for ischernic/reperfused myocardium and
permits a single solution to be used throughout ah phases of the
transplantation procedure. Celsior used as a preservation solution has been
shown to improve post-operative right ventricular function compared to UW
(19) in the ailografi, to better preserve ventricular compliance and contractile
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function compared to St-Thomas’ Hospital solution, and to preserve
endothelium-dependent relaxations to acetylcholine compared to Plegisol
solution after incubation for 15 hours at 40 C (20). A recent study has
dernonstrated that blood cardiopiegia and controlled cardiac graft
reperfusion was associated with iess post-operative myocardial injury and
earlier recovery offunction (21). Previous experiments from our group have
shown that exposure of porcine coronary arteries to cardioplegic arrest with
crystalloid, bÏood, or Celsior cardioplegic solutions ail caused significant
decreases in endothelium-dependent relaxations to serotonin and bradykinin
but that preservation for 4 hours at 40 C with the Celsior solution afier
induction of cardioplegia with crystaiÏoid or Celsior allowed for functional
recovery ofendothelium-dependent relaxations to serotonin and bradykinin.
No studies have cornpared Ceisior to other cardioplegic solutions in terms of
a possible protective effect on coronary endothelial function remote from
transplantation.
Effect of Cardioplegic Solution
Perfusion ofcoronary arteries with either crystalloid, blood, or Celsior
solutions to obtain electromechanicai silence followed by transplantation in
the heterotopic position and expiantation at 30 days causes a decrease in Gi
protein mediated relaxations, as demonstrated by reduced responses to
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serotonin, which acts by binding to 5-HT1d receptors in normal coronary
arteries. The Gi-protein mediated pathway is the rnost sensitive pathway to
injury and one ofthe first affected in nurnerous cardiovascular diseases such
as acute and chronic cardiac rejection (10,22), atherosclerosis (23,24),
hypercholesterolemia, and ischemia-reperfusion injury and serve as an early
rnarker of pathological activation of the endothelium. The Gq- protein
rnediated pathway is more resistant to injury, presumably because
endothelium-dependent relaxations to agonists such as BK are mediated by
the release of both NO and EDHF. Consequently, no significant decrease in
endothelium-dependent relaxation to bradykinin was noted at 30 days in the
groups arrested with blood or Celsior versus controls. Calcium ionophore
mediated relaxations, exerting their effects via a receptor-independent
pathway and representing the final capacity of the endothelium to release
NO afier eNOS stimulation, were significantly aitered in the crystalloid
group versus the blood and Celsior groups. Endotheiium-dependent
relaxations to calcium ionophore were also significantly altered in ail groups
versus controls. Diminished endothelium-dependent relaxations to the
caicium ionophore in ail experirnental groups may be due to either
aiterations in the calcium pooi or membrane permeability to calcium.
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Ail endothelium-dependent relaxations were irnpaired in the
crystalioid arrest group with reduced responses to serotonin, bradykinin, and
the calcium ionophore. This pattem of alteration in endotheiiai vasodiiatory
capacity couid be due to decreased production of NO, increased degradation
of nitric oxide by free radicals, or loss of endothelial ccli coverage. Hearts
arrested with Celsior showed intact endothelium-dependent relaxations to
bradykinin and partially to calcium ionophore probably due to its antioxidant
capacity combined with its ability to reduce celi edema (25). These
properties however did flot prevent the occurrence of a selective endothelial
dysfunction of Gi-protein rnediated relaxations which is likely due to the
effect of immune injury operating in this model (10). Some studies have
shown however that ischemia and reperfusion during transplantation may
cause a selective decrease in G-protein function that may persist up to 3
months afier initiai injury (6,26) without loss of endothelial ccli lining. This
may be due to barotrauma by high perfusion pressures (> 100 mmHg) during
cardiopiegia, mechanical trauma, or immune injury foilowed by subsequent
endothelial regeneration (26). Regenerated endothelial cells from porcine
coronary arteries have a selective impairment of G-protein mediated
vasodilatation (24). In some long terni transplant survivors (> 5 years) the
endothelial function may recover even in the presence of moderate intimal
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disease, which suggests that the state of endothelial function may vary with
the episodic nature of the immune or other injurious factors (5).
Endothelium-independent relaxations mediated by the NO donor sodium
nitroprussiate were unaffected attesting to the integrity of the vascular
smooth muscle ceils which confirms that the reduction ofvascular relaxation
observed in this study is due to endothelium-dependent rnechanisrns.
Histomorphometric Studies
Histomorphometric studies comparing native and aliograft coronary
arteries showed that focal sites of intimai thickening exist constitutively in
coronary arteries of young swine and represent physiologicai intimai
cushions at the site of flow turbulence and bifurcations. There was no
significant difference in the degree of intimai hyperpiasia between coronary
arteries in the controi versus aliografi groups at 30 days aithough there was a
tendency towards a decrease in intimai hyperpiasia in the Ceisior group.
Limitations
A number of iimitations are inherent to this study. In this study, we
used a modei of porcine heterotopic retroperitoneai “non working” type of
cardiac graft in which the coronary arteries are perfused retrogradely
tbrough the recipient aorta. No left ventricular fiuiing occurs in the presence
of a competent aortic valve because of ligation of the pulrnonary veins.
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However, non working heterotopic allografis develop an endothelial
dysftinction comparable to that of working alÏografts 60 days after
transplantation, and has been validated for the study of coronary endothelial
dysfunction (27). Although Celsior in itself is sufficient to induce
cardioplegic arrest, potassium was added in the Y tube during arrest, as with
the two other cardioplegic solutions, to negate the confounding effect of
hyperkalemia on the induction of coronary endothelial function. Endothelial
function was evaluated in terms of its ability to vasodilate porcine coronary
arteries in response to agonists but the presence of normal endothelium was
flot ascertained in this study. However intact relaxation to bradykinin in the
blood and Celsior groups confirms the presence of an endothelial lining. The
ability of blood and Celsior cardioplegia to increase resistance to grafi
rejection was not investigated in this study. The degree of iNOS expression
was not evaluated in this study. NO produced by the inducible form may
lead to free radical damage due to the production of peroxynitrite
contributing to allograft dysfunction. Clinically relevant ischemic tirnes and
preservation conditions were not duplicated in this study but analysis ofthe
effects of the Celsior solution on endothelial function after longer
preservation times is warranted. No immunosuppressive drugs were used to
minimize potential interactions with endothelial function (2$) which enabled
8$
us to isolate the effect of the preservation solution and of immune injury.
Finally, studies of the effects of different cardioplegic solutions on coronary
microvascular function afier transplantation were not evaluated.
Conclusion
Cardioplegic arrest and storage with Celsior or blood constitutes the best
strategies for preservation ofendothelial function of porcine epicardial
arteries afier heart transplantation in this model. Crystalloid cardioplegia
represents the worst rnodality in terms of endothelial reactivity in this model.
Superior preservation of coronary endothelial function may reduce early
graft failure by improving coronary blood flow and serve to lirnit the
development of grafi coronary vasculopathy by preserving the protective
effects ofthe endothelium on the vascular walÏ.
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Figtires and Tables Legends
Table 1: Experirnental groups
figure 1: Cumulative concentration-response curves to serotonin (5-HT) in
rings of porcine coronary arteries with endothelium afier heterotopic heart
transplantation. Responses are given as the percent of relaxation to the
contraction induced by prostaglandin F2Œ. Results are presented as means +
SEM.
figure 2: Cumulative concentration-response curves to bradykinin (BK) in
rings of porcine coronary arteries with endothelium afier heterotopic heart
transplantation. Responses are given as the percent of relaxation to the
contraction induced by prostaglandin F2a. Results are presented as means +
SEM.
figure 3: Cumulative concentration-response curves to calcium ionophore
(A23 187) in rings of porcine coronary arteries with endothelium after
heterotopic heart transplantation. Responses are given as the percent of
relaxation to the contraction induced by prostaglandin F2Œ. Results are
presented as means + SEM.
Table 1:
Groups Cardioplegia Preservation
f Control None Saline
(n=12)
2 (n=4) Crystalloid Saline
3 (n=3) Blood Saline
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Conclusion
Although heart transplantation remains the treatment of choice for
rnedically unresponsive terminal heart disease and is associated with a 5-
year survival of 70%, coronary allograft disease develops in a majority of
transplant recipients and is the main cause of death beyond the first year
afler transplantation. The appearance of accelerated atherosclerosis after
heart transplantation is preceded by reduced dilatations of the coronary
artery to endothelium-dependent agonists, suggesting the presence of an
early endothelial dysfunction. When identified, this dysfunction is predictive
of the development of graft coronary disease one year afier grafi
implantation and of the occurrence of cardiac events and death. The exact
mechanisrns underlying the coronary endothelial dysfunction occurring after
heart transplantation rernain elusive. The time course of coronary endothelial
dysfunction in acute untreated rejection has been characterized and is due to
a progressive destruction of the endothelial lining 5 days afier heart
transplantation which initially involves Gi-protein rnediated relaxations. The
dysfunction worsens over time to affect ah endothelial mechanisms and the
vascular srnooth muscle. The process of transplantation itself exposes
coronary arteries to cardioplegic solutions, cold ischemia, preservation
solutions, and reperfusion after implantation which may cause pathologic
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activation of the endothelium rendering it dysfunctional. Preservation
solutions have been incriminated in the development of allograft
vasculopathy; grafis preserved in intracellular-type (potassium 125 mEq/L)
University of Wisconsin solution were more susceptible to developing
accelerated atherosclerosis over a 36-rnonth follow-up period than those
preserved in extracellular-type (potassium 30 rnEq/L) Stanford solution.
Hyperkalemic preservation solutions can be injurious to the vascular
endothelium by causing direct endothelial denudation and long lasting
effects with the regenerated endothelium failing to recover normal reactivity
and exhibiting an increased tendency to vasospasm. Other mechanisms
involved in initial endothelial injury during cardiac allograft harvesting
include cellular swelling and direct free radical injury on the endothelium.
Celsior solution could potentially protect the endothelium against these
injurious stimuli through its antioxidant properties. The two studies
presented in this manuscript address this hypothesis by examining the
protective role of Celsior on porcine coronary artery endothelial reactivity
following cardioplegia and preservation and the chronic effects ofCelsior on
endothelial function 1 month after heterotopic heart transplantation in a
porcine model.
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The first study was designed to assess the acute effects of different
cardioplegic (Celsior, blood and crystalloid) and preservation (saline,
Celsior) solutions on porcine coronary endothelial function. The findings
indicate that cardioplegia alone using either Celsior, blood, or crystalloid
solutions, causes a decrease in endothelium-dependent relaxations to both
serotonin, 5-HT, an agonist that activates 5-HT1d receptors coupled to Gi
proteins, and bradykinin, BK, which activates B2 receptors coupled to Gq
proteins in porcine coronary arteries. Subsequent preservation in saline does
not produce a recovery of endothelium-dependent relaxations. Induction of
arrest and preservation with Celsior allows for functional recovery of
endothelium-dependent relaxations to both serotonin and bradykinin and thus
better preserves the endothelial function of coronary arteries under these
experimental conditions. The beneficial properties of Celsior are likely related
to its antioxidant capacity, lirniting free radical injury during ischernia and
reducing celi edema. Use ofthis new preservation solution could protect gratis
from the deleterious effects of preservation as suggested by a clinical study in
which use of Celsior was associated with an increased inotropic and
vasodilatory response in transplanted patients in contrast to the University of
Wisconsin solution. The initial endothelial dysfunction to cardioplegic agents
observed was flot caused by irreversible cell injury and denudation but was
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rnost likely the resuit ofbarotrauma and cellular ederna caused by the injection
of solution in the coronary arteries. Celsior preservation allowed functional
recovery of endothelium-dependent relaxations to bradykinin, an agonist
whose vasodilatatory action is rnediated by a Gq-protein pathway known to be
more resistant to injury, but also to serotonin, one of the first pathways
affected in many cardiovascular diseases, such as acute and chronic rejection
and atherosclerosis. Therefore use of the Celsior solution preserves
endothelial function when used during cardioplegia and preservation compared
to saline in a porcine model.
Whether use of Celsior for harvesting during transplantation preserved
grafi coronary endothelial function and limited intimai hyperpiasia remotely
from the time of grafi implantation rernained to be determined. $pecifically,
does Celsior protect the endothelium against reperfusion injury and do these
effects persist 1 month after transplantation ? The second study was
designed to answer this question and examined the effects of Celsior,
crystalloid and sanguineous cardioplegic solutions on porcine coronary
endothelial reactivity and the deveiopment of graft intimal hyperplasia one
month after heterotopic transplantation. The major findings ofthis study are
that 1) use ofCelsior or blood-based cardioplegic solutions confer a superior
protection of epicardial coronary endothelial function one month afier heart
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transplantation cornpared to a crystalloid solution. 2) Ail three preservation
strategies are associated with a significant decrease of Gi-protein rnediated
(5H1) endothelium-dependent relaxations. 3) The use of a crystalioid
solution is associated with a significant decrease of relaxation to the
receptor-independent endothelium-dependent agonist A23 187. 4) There
were no significant differences in allograft coronary intimai hyperpiasia
between experirnental groups. Hearts an-ested with Ceisior showed intact
endothelium-dependent relaxations to bradykinin and partially to calcium
ionophore probably due to its antioxidant capacity cornbined with its ability
to reduce cellular ederna, although these properties did flot prevent the
occurrence of an endothelial dysftinction to Gi-protein mediated relaxation.
The decreased endothelium-dependent relaxations to serotonin are likely due
to graft rejection that occurs in the grafis as the swine were flot treated with
immunosuppressants during the study period as previousiy published (30).
However, sorne studies have shown that ischemia and reperfusion during
transplantation may cause a selective decrease in Gi-protein function that
may persist up to 3 rnonths afier initial injury without loss ofendotheiiai cell
lining which may be due to barotrauma by high perfusion pressures (> 100
mmllg) during cardioplegia, mechanical trauma, or immune injury followed
by subsequent endothelial regeneration since regenerated endotheliai cells
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from porcine coronary arteries have a selective impairment of G-protein
rnediated vasodilatation.
To date, only one study bas examined the comparative role of
cardioplegic solutions on coronary endothelial function one month afier
heart transplantation. The authors found similar resuits when comparing
Celsior and UW solutions. However, immunosuppressive regimens were
different and no data was available regarding the degree ofrejection in both
groups. In the present study, there were no significant differences in the
degree of rejection between the three experimental groups which showed
grade 3B rejection at myocardial biopsy. Consequently, observed differences
in endothelial function are due to the type of arrest and preservation
solutions used at the time of implantation and flot due to differences in the
degree of immune injury. Clinically relevant ischemic times and
preservation conditions were flot duplicated in this study to guarantee
maximum graft survival at 30 days but analysis of the effect of different
solutions on coronary endothelial function and intimai hyperpiasia after
longer preservation times are waiianted. No immunosuppressive drugs were
used to avoid interactions on coronary endothelial function. $ince agents
currently used in clinical heart transplantation such as cyclosporin A,
tacrolimus, sirolimus and mycophenolate mofetil have direct effects on
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coronary endothelial function, experirnental protocols integrating use of
these agents should be devised. Also, the impact of statins and calcium
channel antagonists, both used clinically in ail patients afier heart
transplantation and proven to dirninish the long term occurrence of intimai
hyperpiasia and coronary allografi vasculopathy, was flot evaiuated in this
study. These drugs could have a beneficial effect on endotheiiai function
even one month after the initial transplant procedure and these agents should
be evaluated in future studies.
In conclusion, cardioplegic arrest with Celsior solution or blood and
preservation with Celsior constitutes the best strategy for preservation of
endothelium-dependent relaxations in porcine epicardial coronary arteries
compared to crystalloid solutions 30 days after heart transplantation despite
similar degrees of rejection. Superior preservation of coronary endothelial
function may reduce early graft failure and limit the development of CAV
by maintaining the protective homeostatic effects of the endothelium on the
vascular wall. This in tum could lead to a better long term survival of
patients after heart transplantation and less complications related to
accelerated atherosclerosis. Better cardioplegic and preservation solutions
are one rnodality on which focus can be given in order to better preserve
coronary endothelial function and dirninish the incidence of CAV but one
103
must flot forget that CAV is a multifactorial process that involves
preoperative, intraoperative, and postoperative factors and each of these
elements must be targeted for a more efficacious prevention ofCAV.
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